| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Announcements
|
|
|
2003
|
9 |
11 |
p. 1229-
1 p.
|
artikel
|
| 2 |
Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?
|
Ge, Xupeng
|
|
2003
|
9 |
11 |
p. 1191-1198
8 p.
|
artikel
|
| 3 |
Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat
|
Accatino, Luigi
|
|
2003
|
9 |
11 |
p. 1199-1210
12 p.
|
artikel
|
| 4 |
Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors
|
Lewis, Mark B.
|
|
2003
|
9 |
11 |
p. 1145-1148
4 p.
|
artikel
|
| 5 |
Controversies in the management of hepatitis C virus infection after liver transplantation
|
Shiffman, Mitchell L.
|
|
2003
|
9 |
11 |
p. 1129-1144
16 p.
|
artikel
|
| 6 |
Delayed onset of severe hepatitis C—Related liver damage following liver transplantation: A matter of concern?
|
Berenguer, Marina
|
|
2003
|
9 |
11 |
p. 1152-1158
7 p.
|
artikel
|
| 7 |
Erratum
|
|
|
2003
|
9 |
11 |
p. 1230-
1 p.
|
artikel
|
| 8 |
Hepatitis C pathogenesis: Mechanisms of viral clearance and liver injury
|
Rosen, Hugo R.
|
|
2003
|
9 |
11 |
p. S35-S43
9 p.
|
artikel
|
| 9 |
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection
|
Kugelmas, Marcelo
|
|
2003
|
9 |
11 |
p. 1159-1165
7 p.
|
artikel
|
| 10 |
Hepatocellular carcinoma extension into the right atrium
|
Hayashi, Paul
|
|
2003
|
9 |
11 |
p. 1225-1226
2 p.
|
artikel
|
| 11 |
Host and donor risk factors before and after liver transplantation that impact HCV recurrence
|
Berenguer, Marina
|
|
2003
|
9 |
11 |
p. S44-S47
4 p.
|
artikel
|
| 12 |
How can we identify better those with recurrent hepatitis C who will respond to therapy? What are the optimal treatment regimen and treatment duration?
|
Wright, Teresa L.
|
|
2003
|
9 |
11 |
p. S109-S113
5 p.
|
artikel
|
| 13 |
Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation
|
McCaughan, Geoffrey W.
|
|
2003
|
9 |
11 |
p. S21-S27
7 p.
|
artikel
|
| 14 |
Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence
|
Charlton, Michael
|
|
2003
|
9 |
11 |
p. S58-S62
5 p.
|
artikel
|
| 15 |
Liver donor liver transplantation for fulminant hepatic failure in children
|
Liu, Chi-Leung
|
|
2003
|
9 |
11 |
p. 1185-1190
6 p.
|
artikel
|
| 16 |
Liver transplantation for growing teratoma syndrome: Report of a case
|
Eghtesad, Bijan
|
|
2003
|
9 |
11 |
p. 1222-1224
3 p.
|
artikel
|
| 17 |
Liver transplantation: What do we really know about the long-term impact?
|
Moore, Kathleen A.
|
|
2003
|
9 |
11 |
p. 1149-1151
3 p.
|
artikel
|
| 18 |
Living donor liver transplantation for hepatitis B cirrhosis
|
Sugawara, Yasuhiko
|
|
2003
|
9 |
11 |
p. 1181-1184
4 p.
|
artikel
|
| 19 |
Living donor liver transplantation in patients with hepatitis C
|
Zimmerman, Michael A.
|
|
2003
|
9 |
11 |
p. S52-S57
6 p.
|
artikel
|
| 20 |
Long-term survival of recipients of liver grafts from donors older than 80 years: Is it achievable?
|
Cescon, Matteo
|
|
2003
|
9 |
11 |
p. 1174-1180
7 p.
|
artikel
|
| 21 |
Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation
|
Shiffman, Mitchell L.
|
|
2003
|
9 |
11 |
p. S14-S20
7 p.
|
artikel
|
| 22 |
New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation
|
Davis, Gary L.
|
|
2003
|
9 |
11 |
p. S114-S119
6 p.
|
artikel
|
| 23 |
Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem
|
Carey, Elizabeth J.
|
|
2003
|
9 |
11 |
p. 1166-1173
8 p.
|
artikel
|
| 24 |
Oxygen availability during orthotopic liver transplantation
|
Kostopanagiotou, Georgia
|
|
2003
|
9 |
11 |
p. 1216-1221
6 p.
|
artikel
|
| 25 |
Prophylactic and preemptive therapies for hepatitis C virus—Infected patients undergoing liver transplantation
|
Terrault, Norah A.
|
|
2003
|
9 |
11 |
p. S95-S100
6 p.
|
artikel
|
| 26 |
Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis C
|
Wiesner, Russell H.
|
|
2003
|
9 |
11 |
p. S1-S9
9 p.
|
artikel
|
| 27 |
Retransplantation for recurrent hepatitis C: Positive aspects
|
McCashland, Timothy M.
|
|
2003
|
9 |
11 |
p. S67-S72
6 p.
|
artikel
|
| 28 |
Retransplantation for recurrent hepatitis C: The Argument against
|
Wall, William J.
|
|
2003
|
9 |
11 |
p. S73-S78
6 p.
|
artikel
|
| 29 |
Scope of worldwide hepatitis C problem
|
Brown Jr, Robert S.
|
|
2003
|
9 |
11 |
p. S10-S13
4 p.
|
artikel
|
| 30 |
The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host
|
Braun, Marius
|
|
2003
|
9 |
11 |
p. S79-S89
11 p.
|
artikel
|
| 31 |
The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients
|
Gane, Edward
|
|
2003
|
9 |
11 |
p. S28-S34
7 p.
|
artikel
|
| 32 |
The role of immunosuppression in recurrence of hepatitis C
|
Lake, John R.
|
|
2003
|
9 |
11 |
p. S63-S66
4 p.
|
artikel
|
| 33 |
The sickest first? Disparities with model for end-stage liver disease—Based organ allocation: One region's experience
|
Schaffer III, Randolph L.
|
|
2003
|
9 |
11 |
p. 1211-1215
5 p.
|
artikel
|
| 34 |
The use of hepatitis C-infected grafts in liver transplantation
|
Arenas, Juan I.
|
|
2003
|
9 |
11 |
p. S48-S51
4 p.
|
artikel
|
| 35 |
Treatment of hepatitis C virus infection in the allograft
|
Neuberger, James
|
|
2003
|
9 |
11 |
p. S101-S108
8 p.
|
artikel
|
| 36 |
Treatment of patients with hepatitis C virus on the waiting list
|
Everson, Gregory T.
|
|
2003
|
9 |
11 |
p. S90-S94
5 p.
|
artikel
|
| 37 |
Vancomycin-resistant enterococcal infections: Cause for concern?
|
Snydman, David R.
|
|
2003
|
9 |
11 |
p. 1227-
1 p.
|
artikel
|
Tijdschrift beschrijving